Prolintane
Prolintane is a pyrrolidine-type stimulant formerly used in combination cognition and fatigue products. It is a norepinephrine-dopamine reuptake inhibitor with a moderate stimulant profile and limited modern data.
01 Overview
Prolintane is an older stimulant that was marketed in Europe, sometimes combined with vitamins in products aimed at fatigue and low mood. Structurally it is related to the pyrrolidinophenone stimulants and shares a reuptake-inhibition mechanism.
It produces stimulation and mood elevation with a duration of several hours. Human data is dated and limited, and it has largely fallen out of medical use, persisting mainly as a research-chemical stimulant.
02 Mechanism
Acts as a norepinephrine-dopamine reuptake inhibitor, increasing synaptic catecholamines to produce stimulation.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Light | 20–40 mg | Oral | Anecdotal light range. |
| Common | 40–80 mg | Oral | Approximate historical stimulant dosing. |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| StimulationEnergy, alertness and reduced fatigue. | moderate | Observational | |
| Mood elevationMotivation and mild euphoria at common doses. | Anecdotal |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Cardiovascular strainIncreased heart rate and blood pressure from sympathomimetic activity. | Moderate | Common | Observational | |
| InsomniaDifficulty sleeping after dosing. | Moderate | Common | Anecdotal | |
| Redosing and dependenceReinforcing effects can drive redosing and, with heavy use, dependence. | Moderate | Uncommon | Anecdotal |